Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Manuel Reyes; Michael J. Reardon

doi:10.14797/mdcj-13-3-126

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Manuel Reyes, Michael J. Reardon

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Original language	English (US)
Pages (from-to)	126-131
Number of pages	6
Journal	Methodist DeBakey cardiovascular journal
Volume	13
Issue number	3
DOIs	https://doi.org/10.14797/mdcj-13-3-126
State	Published - Jul 1 2017

Keywords

SAVR
TAVR
expandable valve
surgical aortic valve replacement
transcatheter aortic valve replacement

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.14797/mdcj-13-3-126

Cite this

@article{1bcae9523a7942169569e83c0b7ea648,

title = "Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes",

abstract = "Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.",

keywords = "SAVR, TAVR, expandable valve, surgical aortic valve replacement, transcatheter aortic valve replacement",

author = "Manuel Reyes and Reardon, {Michael J.}",

year = "2017",

month = jul,

day = "1",

doi = "10.14797/mdcj-13-3-126",

language = "English (US)",

volume = "13",

pages = "126--131",

journal = "Methodist DeBakey cardiovascular journal",

issn = "1947-6094",

publisher = "Methodist DeBakey Heart & Vascular Center",

number = "3",

}

TY - JOUR

T1 - Transcatheter Valve Replacement

T2 - Risk Levels and Contemporary Outcomes

AU - Reyes, Manuel

AU - Reardon, Michael J.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

AB - Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

KW - SAVR

KW - TAVR

KW - expandable valve

KW - surgical aortic valve replacement

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85052238126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052238126&partnerID=8YFLogxK

U2 - 10.14797/mdcj-13-3-126

DO - 10.14797/mdcj-13-3-126

M3 - Review article

C2 - 29743997

AN - SCOPUS:85052238126

SN - 1947-6094

VL - 13

SP - 126

EP - 131

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

IS - 3

ER -

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this